Nimbus Therapeutics
We develop breakthrough medicines for patients through precision small molecule design.
99 employees · est. 2009 · Boston, United States
Terremoto Biosciences
Delivers superior small molecule medicines with enhanced therapeutic benefit
49 employees · est. 2021 · South San Francisco, United...
Nimbus Therapeutics is the older company (2009 vs 2021); Nimbus Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Nimbus Therapeutics | Terremoto Biosciences |
|---|---|---|
| Founded | ||
| Founded | 2009 older | 2021 |
| Headquarters | ||
| Headquarters | Boston, United States | South San Francisco, United States |
| Employees | ||
| Employees | 99 larger | 49 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Private Equity | Series C |
| Total Funding | ||
| Total Funding | $637.00M | $358.00M |
| Funding Rounds | ||
| Funding Rounds | 9 | 4 |
| Services | ||
| Services | Target Selection, Drug Discovery, Translational Medicine, Clinical Development, Development of Small Molecule Medicines | Drug Discovery, Small-Molecule Research, Development of Next-Generation Medicines, Therapeutic Innovation |
| Target Customers | ||
| Target Customers | Patients with Oncology Conditions, Patients with Immunological Disorders, Patients with Metabolic Indications, Biotechnology and Pharmaceutical Corporations, Healthcare Professionals | Patients with Cancer, Patients with HHT, Healthcare Professionals, Pharmaceutical Partners |
| Taxonomy | ||
| Taxonomy | Precision Medicine, Small Molecule Design, Structure-based Drug Discovery, Computational Technologies, Machine Learning In Drug Development, Clinical-stage Therapeutics, Oncology, Immunology, Metabolic Diseases, Cancer Treatment, Autoimmune Conditions, HPK1 Inhibitor, WRN Program, Computational Chemistry | Covalent Drug Discovery, Small Molecule Medicines, Lysine-based Covalency, Targeted Therapies, Selectivity In Drug Development, Potency And Efficacy, Best-in-class Therapies, First-in-class Medicines, Undruggable Targets, Therapeutic Benefit, Biotechnological Innovation, OrbiMed Investment, Third Rock Ventures Investment |
| Website | ||
| Website | nimbustx.com | terremotobio.com |
About Nimbus Therapeutics
Nimbus Therapeutics, founded in 2009, is a pioneering biotechnology company headquartered in the United States. The company is dedicated to developing breakthrough medicines through precision small molecule design, leveraging sophisticated computational technologies and machine learning-based predic...
About Terremoto Biosciences
Terremoto Biosciences is making significant strides in the pharmaceutical landscape, leveraging its prowess in covalent drug discovery to craft small molecule medicines noted for their selectivity and potency. Founded in 2021, the company is pioneering therapies that enhance the treatment efficacy a...
We will tell you when either one moves
BounceWatch watches Nimbus Therapeutics and Terremoto Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Nimbus Therapeutics and Terremoto Biosciences — by email.
Frequently Asked Questions
Compare Nimbus Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Nimbus Therapeutics on 15 Jun 2026, and Terremoto Biosciences on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
